1 – 10 of 97
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation
(
- Contribution to journal › Article
- 2023
-
Mark
Plasma levels of CCL21, but not CCL19, independently predict future coronary events in a prospective population-based cohort
(
- Contribution to journal › Article
-
Mark
Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction
(
- Contribution to journal › Article
-
Mark
Invariant natural killer T cells and incidence of first-time coronary events : a nested case-control study
(
- Contribution to journal › Article
-
Mark
Elevated soluble LOX-1 predicts risk of first-time myocardial infarction
(
- Contribution to journal › Article
- 2022
-
Mark
Circulating Interleukin-6 Levels and Incident Ischemic Stroke : A Systematic Review and Meta-analysis of Prospective Studies
(
- Contribution to journal › Scientific review
-
Mark
High levels of autoantibodies against apoB100 p210 are associated with lower incidence of atrial fibrillation in women
(
- Contribution to journal › Article
- 2021
-
Mark
Atherosclerosis : cell biology and lipoproteins
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Association of Circulating Monocyte Chemoattractant Protein-1 Levels with Cardiovascular Mortality : A Meta-analysis of Population-Based Studies
(
- Contribution to journal › Article
-
Mark
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus
(
- Contribution to journal › Article